share_log

BioLine Rx | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

SEC ·  Mar 26 17:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more